BrainStorm Announces New Survival Data from Access Program Cohort: Remarkably 90% of ALS Patients Survived Over 5 Years with NurOwn
On Jun. 16, 2025, BrainStorm Cell Therapeutics announced new survival data from 10 participants in its Expanded Access…